View in EDS

177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study.

Saved in:
Bibliographic Details
Title: 177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study.
Authors: Mandel P; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Groener D; Goethe University Frankfurt, University Hospital, Department of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, Frankfurt am Main, Germany., Follacchio G; Nuclear Medicine Unit, Macerata Hospital, AST, Macerata 62100, Italy., Ürün Y; Medical Oncology, Ankara University Medical Faculty, Ankara, Turkey., Bourlon MT; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Sabet A; Goethe University Frankfurt, Frankfurt am Main, Germany., Grünwald F; Goethe University Frankfurt, Frankfurt am Main, Germany., Tural D; Koç University Hospital, Department of Medical Oncology, Istanbul, Turkey., Büttner T; Department of Urology, University Hospital Bonn (UKB), Bonn, Germany., Kopp RM; Clinical Oncology, Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia., Taha T; Royal Marsden NHS Foundation Trust, London, UK., Chun FK; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany., Facchini G; Oncology Operative Unit, Santa Maria delle Grazie Hospital, Napoli, Pozzuoli ASL NA2 NORD, Italy., Myint ZW; Division of Medical Oncology, Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Seront E; Institut Roi Albert II, Department of Medical Oncology, Cliniques Universitaires Saint Luc, Brussel, Belgium., Conteduca V; Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy., Quiroga MNG; Instituto de Oncologia Ángel H. Roffo, Buenos Aires, Argentina., Aurilio G; Division of Cancer Prevention and Genetics, IRCCS European Institute of Oncology, Milan, Italy., Palacios GA; Department of Medical Oncology, Institutd' Investigació Biomèdica Sant Pau, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain., Bögemann M; Department of Urology, University Hospital Münster, Münster, Germany; West German Cancer Center, Münster, Germany., Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini 6, Florence 50139, Italy., Matrana MR; Department of Internal Medicine, Hematology/Oncology, Ochsner Medical Center, New Orleans, LA, USA., Sammarco E; Medical Oncology Unit, Livorno Hospital, Azienda Toscana Nord Ovest, Livorno 57124, Italy., Laguado MIZ; Internal Medicine, Universidad El Bosque, Bogotá, Colombia., Galli L; Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Ansari J; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates., Danielli L; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Molina-Cerrillo J; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Rescigno P; Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Yazgan SC; Medical Oncology, Ankara University Medical Faculty, Ankara, Turkey., Bastos DA; Department of Medical Oncology, Hospital Sírio-Libanês, São Paulo, Brazil., Jazieh AR; Cincinnati Cancer Advisors, Cincinnati, OH, USA., Monteiro FSM; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil; Hospital Sírio-Libanês, Brasília, DF, Brazil., Soares A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Wenzel M; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany. Electronic address: Mike.Wenzel@unimedizin-ffm.de., Capoccetti F; Nuclear Medicine Unit, Macerata Hospital, AST, Macerata 62100, Italy., Santoni M; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Oct 16; Vol. 229, pp. 115789. Date of Electronic Publication: 2025 Sep 12.
Publication Type: Journal Article; Multicenter Study; Comparative Study
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40987027
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: <superscript>177</superscript>Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mandel+P%22">Mandel P</searchLink>; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Groener+D%22">Groener D</searchLink>; Goethe University Frankfurt, University Hospital, Department of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Follacchio+G%22">Follacchio G</searchLink>; Nuclear Medicine Unit, Macerata Hospital, AST, Macerata 62100, Italy.<br /><searchLink fieldCode="AU" term="%22Ürün+Y%22">Ürün Y</searchLink>; Medical Oncology, Ankara University Medical Faculty, Ankara, Turkey.<br /><searchLink fieldCode="AU" term="%22Bourlon+MT%22">Bourlon MT</searchLink>; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Sabet+A%22">Sabet A</searchLink>; Goethe University Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Grünwald+F%22">Grünwald F</searchLink>; Goethe University Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Tural+D%22">Tural D</searchLink>; Koç University Hospital, Department of Medical Oncology, Istanbul, Turkey.<br /><searchLink fieldCode="AU" term="%22Büttner+T%22">Büttner T</searchLink>; Department of Urology, University Hospital Bonn (UKB), Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Kopp+RM%22">Kopp RM</searchLink>; Clinical Oncology, Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia.<br /><searchLink fieldCode="AU" term="%22Taha+T%22">Taha T</searchLink>; Royal Marsden NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Chun+FK%22">Chun FK</searchLink>; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Facchini+G%22">Facchini G</searchLink>; Oncology Operative Unit, Santa Maria delle Grazie Hospital, Napoli, Pozzuoli ASL NA2 NORD, Italy.<br /><searchLink fieldCode="AU" term="%22Myint+ZW%22">Myint ZW</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.<br /><searchLink fieldCode="AU" term="%22Seront+E%22">Seront E</searchLink>; Institut Roi Albert II, Department of Medical Oncology, Cliniques Universitaires Saint Luc, Brussel, Belgium.<br /><searchLink fieldCode="AU" term="%22Conteduca+V%22">Conteduca V</searchLink>; Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy.<br /><searchLink fieldCode="AU" term="%22Quiroga+MNG%22">Quiroga MNG</searchLink>; Instituto de Oncologia Ángel H. Roffo, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Aurilio+G%22">Aurilio G</searchLink>; Division of Cancer Prevention and Genetics, IRCCS European Institute of Oncology, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Palacios+GA%22">Palacios GA</searchLink>; Department of Medical Oncology, Institutd' Investigació Biomèdica Sant Pau, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bögemann+M%22">Bögemann M</searchLink>; Department of Urology, University Hospital Münster, Münster, Germany; West German Cancer Center, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Roviello+G%22">Roviello G</searchLink>; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini 6, Florence 50139, Italy.<br /><searchLink fieldCode="AU" term="%22Matrana+MR%22">Matrana MR</searchLink>; Department of Internal Medicine, Hematology/Oncology, Ochsner Medical Center, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Sammarco+E%22">Sammarco E</searchLink>; Medical Oncology Unit, Livorno Hospital, Azienda Toscana Nord Ovest, Livorno 57124, Italy.<br /><searchLink fieldCode="AU" term="%22Laguado+MIZ%22">Laguado MIZ</searchLink>; Internal Medicine, Universidad El Bosque, Bogotá, Colombia.<br /><searchLink fieldCode="AU" term="%22Galli+L%22">Galli L</searchLink>; Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Ansari+J%22">Ansari J</searchLink>; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Danielli+L%22">Danielli L</searchLink>; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Molina-Cerrillo+J%22">Molina-Cerrillo J</searchLink>; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rescigno+P%22">Rescigno P</searchLink>; Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Yazgan+SC%22">Yazgan SC</searchLink>; Medical Oncology, Ankara University Medical Faculty, Ankara, Turkey.<br /><searchLink fieldCode="AU" term="%22Bastos+DA%22">Bastos DA</searchLink>; Department of Medical Oncology, Hospital Sírio-Libanês, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Jazieh+AR%22">Jazieh AR</searchLink>; Cincinnati Cancer Advisors, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Monteiro+FSM%22">Monteiro FSM</searchLink>; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil; Hospital Sírio-Libanês, Brasília, DF, Brazil.<br /><searchLink fieldCode="AU" term="%22Soares+A%22">Soares A</searchLink>; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.<br /><searchLink fieldCode="AU" term="%22Massari+F%22">Massari F</searchLink>; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Wenzel+M%22">Wenzel M</searchLink>; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany. Electronic address: Mike.Wenzel@unimedizin-ffm.de.<br /><searchLink fieldCode="AU" term="%22Capoccetti+F%22">Capoccetti F</searchLink>; Nuclear Medicine Unit, Macerata Hospital, AST, Macerata 62100, Italy.<br /><searchLink fieldCode="AU" term="%22Santoni+M%22">Santoni M</searchLink>; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2025 Oct 16; Vol. 229, pp. 115789. <i>Date of Electronic Publication: </i>2025 Sep 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40987027
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2025.115789
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 115789
    Titles:
      – TitleFull: 177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mandel P
      – PersonEntity:
          Name:
            NameFull: Groener D
      – PersonEntity:
          Name:
            NameFull: Follacchio G
      – PersonEntity:
          Name:
            NameFull: Ürün Y
      – PersonEntity:
          Name:
            NameFull: Bourlon MT
      – PersonEntity:
          Name:
            NameFull: Sabet A
      – PersonEntity:
          Name:
            NameFull: Grünwald F
      – PersonEntity:
          Name:
            NameFull: Tural D
      – PersonEntity:
          Name:
            NameFull: Büttner T
      – PersonEntity:
          Name:
            NameFull: Kopp RM
      – PersonEntity:
          Name:
            NameFull: Taha T
      – PersonEntity:
          Name:
            NameFull: Chun FK
      – PersonEntity:
          Name:
            NameFull: Facchini G
      – PersonEntity:
          Name:
            NameFull: Myint ZW
      – PersonEntity:
          Name:
            NameFull: Seront E
      – PersonEntity:
          Name:
            NameFull: Conteduca V
      – PersonEntity:
          Name:
            NameFull: Quiroga MNG
      – PersonEntity:
          Name:
            NameFull: Aurilio G
      – PersonEntity:
          Name:
            NameFull: Palacios GA
      – PersonEntity:
          Name:
            NameFull: Bögemann M
      – PersonEntity:
          Name:
            NameFull: Roviello G
      – PersonEntity:
          Name:
            NameFull: Matrana MR
      – PersonEntity:
          Name:
            NameFull: Sammarco E
      – PersonEntity:
          Name:
            NameFull: Laguado MIZ
      – PersonEntity:
          Name:
            NameFull: Galli L
      – PersonEntity:
          Name:
            NameFull: Ansari J
      – PersonEntity:
          Name:
            NameFull: Danielli L
      – PersonEntity:
          Name:
            NameFull: Molina-Cerrillo J
      – PersonEntity:
          Name:
            NameFull: Rescigno P
      – PersonEntity:
          Name:
            NameFull: Yazgan SC
      – PersonEntity:
          Name:
            NameFull: Bastos DA
      – PersonEntity:
          Name:
            NameFull: Jazieh AR
      – PersonEntity:
          Name:
            NameFull: Monteiro FSM
      – PersonEntity:
          Name:
            NameFull: Soares A
      – PersonEntity:
          Name:
            NameFull: Massari F
      – PersonEntity:
          Name:
            NameFull: Wenzel M
      – PersonEntity:
          Name:
            NameFull: Capoccetti F
      – PersonEntity:
          Name:
            NameFull: Santoni M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 10
              Text: 2025 Oct 16
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 229
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1